You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

POTASSIUM CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for potassium chloride and what is the scope of patent protection?

Potassium chloride is the generic ingredient in forty-five branded drugs marketed by Savage Labs, Upsher Smith Labs, Nesher Pharms, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Chartwell Molecular, Glenmark Pharms Ltd, Granules, Lupin Ltd, Novel Labs Inc, Padagis Us, Ph Health, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Genus, Ajenat Pharms, Amneal, Anda Repository, Epic Pharma Llc, Novitium Pharma, Rubicon Research, Kv Pharm, Abraxis Pharm, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Nexus, Pharma Serve Ny, Watson Labs, Otsuka Icu Medcl, Genus Lifesciences, Apotex, Ascent Pharms Inc, Aurobindo Pharma, Macleods Pharms Ltd, Pharm Assoc, Quagen, Sciegen Pharms, Taro, Wes Pharma Inc, Future Pak, Abbvie, Apothecon, Aurobindo Pharma Ltd, Breckenridge, Chartwell Rx, Copley Pharm, Guangzhou Novaken, Pharmobedient, Rising, Schering, Sigmapharm Labs Llc, Twi Pharms, Yichang Humanwell, and Novartis, and is included in one hundred and thirty-eight NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for potassium chloride. Eighty-one suppliers are listed for this compound. There are two tentative approvals for this compound.

Drug Prices for POTASSIUM CHLORIDE

See drug prices for POTASSIUM CHLORIDE

Drug Sales Revenue Trends for POTASSIUM CHLORIDE

See drug sales revenues for POTASSIUM CHLORIDE

Generic filers with tentative approvals for POTASSIUM CHLORIDE
Applicant Application No. Strength Dosage Form
⤷  Start Trial⤷  Start Trial20MEQTablet; Oral
⤷  Start Trial⤷  Start Trial10MEQTablet, Extended Release; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for POTASSIUM CHLORIDE

US Patents and Regulatory Information for POTASSIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc POTASSIUM CHLORIDE potassium chloride FOR SOLUTION;ORAL 210241-001 Nov 21, 2018 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Tris Pharma Inc POTASSIUM CHLORIDE potassium chloride SOLUTION;ORAL 214076-002 Jan 26, 2022 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
B Braun SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 018722-001 Nov 9, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Novel Labs Inc POTASSIUM CHLORIDE potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 204828-002 Aug 16, 2016 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for POTASSIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Nesher Pharms MICRO-K potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-001 Approved Prior to Jan 1, 1982 4,259,315 ⤷  Start Trial
Schering POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 019439-001 Jun 13, 1986 4,863,743 ⤷  Start Trial
Nesher Pharms MICRO-K 10 potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 018238-002 May 14, 1984 4,259,315 ⤷  Start Trial
Schering POTASSIUM CHLORIDE potassium chloride TABLET, EXTENDED RELEASE;ORAL 019439-002 Jun 13, 1986 4,863,743 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Market Dynamics and Financial Trajectory for Potassium Chloride

Last updated: February 19, 2026

Potassium chloride (KCl) is predominantly used as a dietary supplement for potassium replenishment and as a fertilizer additive. Its market size, growth drivers, and revenue projections are driven by agriculture, healthcare, and industrial sectors.

Market Overview

The global potassium chloride market was valued at approximately USD 15 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4-5% through 2030, reaching over USD 20 billion [1].

Key sectors influencing the market include:

  • Agriculture: Fertilizer applications account for nearly 95% of demand.
  • Healthcare: Used as a supplement for hypokalemia treatment.
  • Industrial Uses: Variations in industrial demand are limited relative to agriculture and healthcare.

Market Drivers

Agriculture Sector

The increased demand for food production globally fuels fertilizer consumption. Potassium is a critical nutrient for crop yield, soil health, and plant resistance. Governments in emerging markets invest heavily in fertilizer infrastructure, propelling KCl demand.

Healthcare Sector

Rising prevalence of conditions linked to potassium deficiency, such as cardiovascular diseases, boosts demand for KCl-based supplements and infusion solutions. Aging populations in North America and Europe further drive healthcare consumption.

Supply Chain Factors

  • Major producers include Canada, Russia, Belarus, and Chile.
  • Russia and Belarus account for approximately 35-40% of global exports [2].
  • Supply disruptions from geopolitical tensions, sanctions, or weather impact prices and availability.

Market Challenges

  • Price volatility due to geopolitical conflicts and weather events.
  • Environmental concerns over mining practices and associated emissions.
  • Competition from alternative potassium sources like sulfate forms and organic fertilizers.

Financial Trajectory

Revenue Growth

The market's revenue is expected to expand from USD 15 billion in 2022 to approximately USD 20 billion by 2030, representing a CAGR of 4-5%. Growth is primarily driven by fertilizer demand, with healthcare's contribution expanding at a steady pace.

Pricing Trends

The average FOB (Free On Board) price of potassium chloride fluctuated between USD 200-300 per ton in 2022. Price sensitivity to supply disruptions has increased, with spikes reaching USD 350/ton during shortages [3].

Investment Patterns

  • Capital expenditure on mining and processing facilities is increasing.
  • R&D efforts focus on producing eco-friendlier mining technologies and alternative formulations.

Competitive Landscape

Major players include Nutrien Ltd., Mosaic Company, OCP Group, and Canada-based Nutrien. Consolidation and mergers occur periodically to maintain market share amid price fluctuations.

Future Outlook

The market outlook remains stable with moderate growth. Industry shifts toward sustainable mining and environmentally friendly fertilizer options are expected to shape future investments. Regulatory pressures concerning mining practices could influence supply prices.

Year Market Value (USD Billion) CAGR Notes
2022 15 Baseline year
2025 17.5 4-5% Projected mid-term growth
2030 20 4-5% Target market size

Key Takeaways

  • Potassium chloride's market size exceeds USD 15 billion, with steady growth driven by agriculture and healthcare.
  • Supply concentrations in Russia and Belarus create volatility and price sensitivity.
  • Prices fluctuate between USD 200-350/ton, influenced by geopolitical and weather factors.
  • Major industry players continue to invest in capacity expansion and sustainability initiatives.
  • The outlook points to stable growth with emerging environmental regulations affecting supply dynamics.

FAQs

Q1: What are the main uses of potassium chloride?
Primarily used as a fertilizer additive to supply potassium in agriculture and as a potassium supplement in healthcare for treating hypokalemia.

Q2: Which regions are the largest consumers of potassium chloride?
North America, Europe, and Asia-Pacific. Europe and North America see increased healthcare demand; Asia-Pacific leads in fertilizer consumption.

Q3: How do geopolitical tensions affect the market?
Tensions involving Russia, Belarus, or other key exporters can reduce supply, increase prices, and create market volatility.

Q4: Are there alternatives to potassium chloride?
Yes; potassium sulfate and organic fertilizers can replace KCl, but they are often more expensive or less efficient in certain applications.

Q5: What are environmental concerns related to potassium chloride mining?
Mining can cause land degradation, water contamination, and emissions. Regulatory pressures are pushing for more sustainable practices.


References

[1] Markets and Markets. (2023). Potassium chloride market report.
[2] US Geological Survey. (2022). Mineral commodity summaries: Potassium.
[3] ICIS. (2022). Potassium chloride price analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.